Based on data from the past 90 days ending December 12, 2025, Sarepta Therapeutics's three largest insider shareholders are Chief Executive Officer Douglas S Ingram (929.39K shares), President And R&D And Tech Ops Louise Rodino-Klapac (224.03K shares), EVP And General Counsel Cristin Rothfuss (139.76K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Richard Barry | 3,106,667 | 19 May, 2025 | |
| Douglas S Ingram | Chief Executive Officer | 929,391 | 09 Dec, 2025 |
| Michael Andrew Chambers | 294,694 | 11 Mar, 2025 | |
| Louise Rodino-Klapac | President And R&D And Tech Ops | 224,030 | 19 Nov, 2025 |
| Ian Michael Estepan | Chief Operating Officer | 206,487 | 05 Sep, 2025 |
| M Kathleen Behrens | 193,476 | 11 Mar, 2025 | |
| Cristin Rothfuss | EVP And General Counsel | 139,756 | 02 Dec, 2025 |
| Ryan Ho-Yan Wong | Chief Financial Officer | 136,045 | 10 Dec, 2025 |
| Dallan Murray | Chief Customer Officer | 38,202 | 11 Mar, 2025 |
| Bilal Arif | Chief Tech Ops Officer | 32,500 | 11 Mar, 2025 |
| Gilmore Neil O'Neill | EVP And R&D & Cmo | 29,070 | 05 Mar, 2021 |
| Claude Nicaise | 27,812 | 13 Mar, 2025 | |
| Hans Lennart Rudolf Wigzell | 25,223 | 11 Mar, 2025 | |
| William Ciambrone | EVP | 22,099 | 08 Mar, 2022 |
| Ryan Edward Brown | EVP And General Counsel | 17,129 | 25 Jun, 2024 |
| Mary Ann Gray | 12,356 | 08 Mar, 2022 | |
| Stephen Mayo | 9,004 | 11 Mar, 2025 | |
| Kathryn Jean Boor | 8,263 | 11 Mar, 2025 | |
| John C Martin | 7,913 | 05 Mar, 2021 | |
| Deirdre P Connelly | 5,225 | 11 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 50,000 | $0.00 | 440,307 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 50,000 | $0.00 | 490,307 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 73,001 | $0.00 | 563,308 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 96,541 | $0.00 | 659,849 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 269,542 | $0.00 | 929,391 | D | A |
| 01 Dec, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 80 | $20.96 | 136,123 | D | F |
| 01 Dec, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 78 | $20.96 | 136,045 | D | F |
| 28 Nov, 2025 | Cristin Rothfuss | Common Stock | D | 229 | $21.12 | 139,756 | D | F |
| 17 Nov, 2025 | Louise Rodino-Klapac | Common Stock | D | 4,582 | $18.42 | 224,030 | D | F |
| 03 Sep, 2025 | Louise Rodino-Klapac | Common Stock | A | 93,875 | $0.00 | 178,612 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | - | - | 156,487 | D | |||
| 03 Sep, 2025 | Ryan Ho-Yan Wong | Common Stock | A | 93,875 | $0.00 | 111,203 | D | A |
| 03 Sep, 2025 | Cristin Rothfuss | Common Stock | A | 93,875 | $0.00 | 114,985 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | Common Stock | A | 93,875 | $0.00 | 156,487 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | - | - | 206,487 | D | |||
| 03 Sep, 2025 | Louise Rodino-Klapac | Common Stock | A | 50,000 | $0.00 | 228,612 | D | A |
| 03 Sep, 2025 | Ryan Ho-Yan Wong | Common Stock | A | 25,000 | $0.00 | 136,203 | D | A |
| 03 Sep, 2025 | Cristin Rothfuss | Common Stock | A | 25,000 | $0.00 | 139,985 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | Common Stock | A | 50,000 | $0.00 | 206,487 | D | A |
| 31 Jul, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 327 | $16.42 | 17,328 | D | F |